Comparing midline catheters and long peripheral intravenous catheters for hospitalized adults
Midline Catheter Versus Long Peripheral Intravenous Catheter in Hospitalized Adult Patients: Randomized Clinical Trial With Economic Analysis From the Perspective of the Public Health System.
This study tests whether midline catheters or long peripheral intravenous catheters work better for hospitalized adults needing IV therapy and how long each can be used without problems.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 102 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospital de Clinicas de Porto Alegre Academic / other |
| Locations | 1 site (Porto Alegre, Rio Grande Do Sul) |
| Trial ID | NCT05884294 on ClinicalTrials.gov |
What this trial studies
This research compares the effectiveness of midline catheters versus long peripheral intravenous catheters in hospitalized adult patients requiring intravenous therapy. Patients will be randomly assigned to receive one of the two catheter types, and the study will evaluate how long each catheter can be used without complications such as swelling, clogging, or infection. Additionally, an economic analysis will assess the costs associated with any complications that arise during the treatment period. The trial aims to provide insights into the best vascular access device for patients with difficult intravenous access.
Who should consider this trial
Good fit: Ideal candidates are hospitalized adults with difficult intravenous access who require intravenous therapy for more than five days.
Not a fit: Patients who do not require intravenous therapy or those with uncomplicated intravenous access may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient outcomes and reduced complications associated with vascular access devices.
How similar studies have performed: Other studies have explored various vascular access devices, but this specific comparison of midline versus long peripheral catheters is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
* patients hospitalized in a clinical ward unit; * indicated for continuous or intermittent intravenous therapy more than five days; * identified with difficult intravenous access.
Where this trial is running
Porto Alegre, Rio Grande Do Sul
- Hospital de Clínicas de Porto Alegre — Porto Alegre, Rio Grande Do Sul, Brazil (Recruiting)
Study contacts
- Principal investigator: Eneida R Rabelo da Silva, ScD — Hospital de Clínicas de Porto Alegre
- Study coordinator: Eneida R Rabelo da Silva, ScD
- Email: esilva@hcpa.edu.br
- Phone: 55 51 33598084
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.